Prapela
Biddeford
About Prapela
Prapela is an affordable, noninvasive stimulation therapy that improves newborn health. Our focus is on three clinical problems experienced by thousands of newborns every day. Placed inside a hospital bassinet or incubator, our reusable pad provides gentle stimulation that helps improve the natural processes of breathing control and oxygenation. Since receiving our first award in 2017, Prapela has become America's most-awarded pediatric medical device startup. With over $8M in grants (and hopefully more), we are honored and motivated to work with neonatologists, the National Institutes of Health, and the FDA to improve the health of newborns.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.2M
- Last round: Grant (Dec 2023)
- Website: prapela.com
- Phone: 833-772-7352
Industries & Categories
Children, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/prapela-137543 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.